OpenLegislation

Regulation 25 Distance selling premises applications

United Kingdom

(1)

Section 129(2A) of the 2006 Act M1 (regulations as to pharmaceutical services) does not apply to an application F1to relocate to different premises—

F2(a)

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(b)

by a person already included in a pharmaceutical list for inclusion in that list F3...in respect of premises other than those already listed in relation to that person,

in respect of pharmacy premises that are distance selling premises.

(2)

F4NHS England must refuse an application to which paragraph (1) applies—

(a)

if the premises in respect of which the application is made are on the same site or in the same building as the premises of a provider of primary medical services with a patient list; and

(b)

unless NHS England is satisfied that the pharmacy procedures for the pharmacy premises are likely to secure—

(i)

the uninterrupted provision of essential services, during the opening hours of the premises, to persons anywhere in England who request those services, and

(ii)

the safe and effective provision of F5pharmaceutical services without face to face contact F6at the pharmacy premises between any person receiving the services, whether on their own or on someone else's behalf, and the applicant or the applicant's staff.

Annotations

Textual amendments

F1

Words in reg. 25(1) inserted (23.6.2025) by The National Health Service (Charges, Remission of Charges and Pharmaceutical Services etc.) (Amendment and Transitional Provisions) Regulations 2025 (S.I. 2025/636), regs. 1(2), 7(2)(a)

F2

Reg. 25(1)(a) omitted (23.6.2025) by virtue of The National Health Service (Charges, Remission of Charges and Pharmaceutical Services etc.) (Amendment and Transitional Provisions) Regulations 2025 (S.I. 2025/636), regs. 1(2), 7(2)(b)

F3

Word in reg. 25(1)(b) omitted (1.3.2015) by virtue of The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment and Transitional Provision) Regulations 2015 (S.I. 2015/58), regs. 1(1), 2 (with reg. 10)

F4

Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1

F5

Words in reg. 25(2)(b)(ii) substituted (23.6.2025) by The National Health Service (Charges, Remission of Charges and Pharmaceutical Services etc.) (Amendment and Transitional Provisions) Regulations 2025 (S.I. 2025/636), regs. 1(2), 7(3)(a)

F6

Words in reg. 25(2)(b)(ii) inserted (23.6.2025) by The National Health Service (Charges, Remission of Charges and Pharmaceutical Services etc.) (Amendment and Transitional Provisions) Regulations 2025 (S.I. 2025/636), regs. 1(2), 7(3)(b)

Marginal citations

M1

Section 129(2A) was inserted by the Health Act 2009 (c. 21), section 26(3), and has been amended by the Health and Social Care Act 2012 (c. 7), section 207(4), and Schedule 4, paragraph 66(5).